In vitro antimicrobial activity of Naja cardiotoxin peptide-3 against clinical isolates from canine otitis

Costanza Spadini1, Nicolò Mezzasalma2, Alessandro Cupola1

  • 1Department of Veterinary Science, University of Parma, Strada del Taglio 10, Parma, 43126, Italy.

Insights

Naja Cardiotoxin Peptide-3 (NCP-3) shows potent antimicrobial activity against Gram-positive bacteria common in canine otitis externa. This peptide offers a promising alternative to conventional therapies facing antimicrobial resistance.

Area of Science:

  • Veterinary Dermatology
  • Antimicrobial Peptides
  • Drug Discovery

Background:

  • Canine otitis externa is frequently complicated by bacterial and fungal infections.
  • Antimicrobial resistance necessitates novel therapeutic strategies.
  • Antimicrobial peptides (AMPs) offer broad-spectrum activity with low resistance potential.

Purpose of the Study:

  • To evaluate the in vitro antimicrobial activity of Naja Cardiotoxin Peptide-3 (NCP-3) against clinical isolates from canine otitis externa.
  • To assess NCP-3's efficacy against multidrug-resistant bacteria and Malassezia pachydermatis.
  • To compare NCP-3's activity against Gram-positive and Gram-negative bacteria.

Main Methods:

  • In vitro evaluation of NCP-3's Minimum Bactericidal Concentration (MBC) and Minimum Inhibitory Concentration (MIC).
  • Testing against reference strains and clinical isolates from dogs with otitis externa.
  • Time-kill assays to determine bactericidal kinetics.

Main Results:

  • NCP-3 demonstrated potent activity against Staphylococcus pseudintermedius (MBC₅₀=3.1 µg/mL; MBC₉₀=6.3 µg/mL).
  • Activity was lower against Pseudomonadaceae, Enterobacteriaceae, and Malassezia pachydermatis.
  • Rapid bactericidal activity against Gram-positive strains was observed within five minutes.

Conclusions:

  • NCP-3 exhibits significant antimicrobial activity against Gram-positive bacteria, including resistant strains.
  • NCP-3 shows less efficacy against Gram-negative bacteria and Malassezia pachydermatis.
  • NCP-3 is a potential therapeutic candidate for canine otitis externa caused by Gram-positive pathogens.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...